Copaxone and Injection site swelling - a phase IV clinical study of FDA data
We study 55,350 people who have side effects when taking Copaxone. Injection site swelling is found, especially among people who are female, 50-59 old, have been taking the drug for 1 - 6 months, also take Vitamin d and have Clinically isolated syndrome.
The phase IV clinical study analyzes which people take Copaxone and have Injection site swelling. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
55,350 people reported to have side effects when taking Copaxone.
Among them, 1,187 people (2.14%) have Injection site swelling.
What is Copaxone?
Copaxone has active ingredients of glatiramer acetate. It is used in multiple sclerosis. Currently, eHealthMe is studying from 55,935 Copaxone users.
What is Injection site swelling?
Injection site swelling is found to be associated with 1,674 drugs and 1,077 conditions by eHealthMe. Currently, we are studying 64,994 people who have Injection site swelling.
Number of Copaxone and Injection site swelling reports submitted per year:
Time on Copaxone when people have Injection site swelling *:
Gender of people who have Injection site swelling when taking Copaxone*:
Age of people who have Injection site swelling when taking Copaxone *:
Common drugs people take besides Copaxone *:
Common side effects people have besides Injection site swelling *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Copaxone and have Injection site swelling?Check whether Injection site swelling is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Copaxone side effects by duration, gender and age:
- Copaxone side effects (55,935 reports)
Injection site swelling treatments and more:
- Injection site swelling (64,994 reports)
Common drugs associated with Injection site swelling:
- Enbrel: 24,289 reports
- Humira: 8,660 reports
- Methotrexate: 3,931 reports
- Dupixent: 2,183 reports
- Repatha: 2,031 reports
- Prednisone: 1,813 reports
- Taltz: 1,310 reports
- Copaxone: 1,187 reports
- Metformin: 1,113 reports
- Botox: 1,024 reports
All the drugs that are associated with Injection site swelling:
- Injection site swelling (1,674 drugs)
Common conditions associated with Injection site swelling:
- Rheumatoid arthritis: 16,901 reports
- Psoriasis: 5,693 reports
- Crohn's disease: 2,634 reports
- Multiple sclerosis: 2,528 reports
All the conditions that are associated with Injection site swelling:
- Injection site swelling (1,077 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Copaxone) and Copaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cotellic and Alanine Aminotransferase Increased - 50 seconds ago
- Avastin and Cialis drug interaction - 52 seconds ago
- Excedrin and Itching - a minute ago
- Ketorolac Tromethamine and Renal Ischaemia - a minute ago
- Paracetamol and Neonatal Respiratory Acidosis - a minute ago
- Tykerb and Temaz drug interaction - a minute ago
- Oxybutynin and Doxycycline drug interaction - a minute ago
- Biotin and Thrombocytopenia - a minute ago
- Azopt and Inderal drug interaction - a minute ago
- Didanosine and Blood Albumin Decreased - a minute ago